From the *Department of Nuclear Medicine & PET, †Cytology and Gynaecological Pathology, and ‡Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Clin Nucl Med. 2015 Mar;40(3):256-7. doi: 10.1097/RLU.0000000000000622.
Pancreatic neuroendocrine tumors (PNETs) represent a small percentage of all pancreatic malignancies, and most of these present as metastatic disease. Somatostatin receptor scintigraphy had been used successfully for the assessment of patients with NET. Somatostatin receptor scintigraphy is indispensable for localization of ectopic NET and the distribution of NET throughout the body.
胰腺神经内分泌肿瘤（PNETs）在所有胰腺恶性肿瘤中所占比例较小，其中大多数为转移性疾病。生长抑素受体闪烁显像术已成功用于评估 NET 患者。生长抑素受体闪烁显像术对于异位 NET 的定位和 NET 在全身的分布是不可或缺的。
